These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6956704)

  • 1. Immediate and long-term posttherapy neuropsychologic performance in children with acute lymphoblastic leukemia treated without central nervous system radiation.
    Tamaroff M; Miller DR; Murphy ML; Salwen R; Ghavimi F; Nir Y
    J Pediatr; 1982 Oct; 101(4):524-9. PubMed ID: 6956704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of central-nervous-system irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia.
    Soni SS; Marten GW; Pitner SE; Duenas DA; Powazek M
    N Engl J Med; 1975 Jul; 293(3):113-8. PubMed ID: 1055858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
    Haghbin M; Tan CT; Clarkson BD; Miké V; Burchenal JH; Murphy ML
    Cancer Res; 1975 Mar; 35(3):807-11. PubMed ID: 1054287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia.
    Moss HA; Nannis ED; Poplack DG
    Am J Med; 1981 Jul; 71(1):47-52. PubMed ID: 6941699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second central nervous system prophylaxis in children with acute lymphoblastic leukemia who relapse after elective cessation of therapy.
    Rivera G; George SL; Bowman WP; Kalwinsky D; Ochs J; Dahl GV; Hustu HO; Simone JV
    J Clin Oncol; 1983 Aug; 1(8):471-6. PubMed ID: 6583322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia.
    Rowland JH; Glidewell OJ; Sibley RF; Holland JC; Tull R; Berman A; Brecher ML; Harris M; Glicksman AS; Forman E
    J Clin Oncol; 1984 Dec; 2(12):1327-35. PubMed ID: 6595350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL).
    Littman P; Coccia P; Bleyer WA; Lukens J; Siegel S; Miller D; Sather H; Hammond D
    Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1443-9. PubMed ID: 3305443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
    Ribeiro RC; Rivera GK; Hudson M; Mulhern RK; Hancock ML; Kun L; Mahmoud H; Sandlund JT; Crist WM; Pui CH
    J Clin Oncol; 1995 Feb; 13(2):333-8. PubMed ID: 7844594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent intrathecal methotrexate and fractional radiation (M-IMFRA) plus chemotherapy in childhood leukemia.
    Mastrangelo R; Romanini A; Cellini N; Parenti D; De Renzis C; Riccardi R; Cimatti G; Malandrino R
    Tumori; 1978; 64(6):607-11. PubMed ID: 283624
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of meningeal CNS involvement as a factor influencing the duration of complete remission and survival in childhood acute lymphoblastic leukemia.
    Madon E; Cordero di Montezemolo L; Pastore G
    Tumori; 1977; 63(4):367-72. PubMed ID: 270863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy.
    Peylan-Ramu N; Poplack DG; Pizzo PA; Adornato BT; Di Chiro G
    N Engl J Med; 1978 Apr; 298(15):815-8. PubMed ID: 273143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation.
    Kun LE; Camitta BM; Mulhern RK; Lauer SJ; Kline RW; Casper JT; Kamen BA; Kaplan BM; Barber SW
    J Clin Oncol; 1984 May; 2(5):359-64. PubMed ID: 6587015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylactic central nervous system irradiation for childhood acute lymphoblastic leukemia].
    Chatani M; Teshima T; Inoue T; Azuma I; Kumano M; Hishikawa Y; Kondo K; Suyama T; Yabumoto E; Nakajima T
    Gan No Rinsho; 1984 Apr; 30(4):363-7. PubMed ID: 6587134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the assessment of neurotoxicity in children with acute lymphoblastic leukemia.
    Muchi H; Satoh T; Yamamoto K; Karube T; Miyao M
    Cancer; 1987 Mar; 59(5):891-5. PubMed ID: 3469009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with IQ scores in long-term survivors of childhood acute lymphoblastic leukemia.
    Robison LL; Nesbit ME; Sather HN; Meadows AT; Ortega JA; Hammond GD
    Am J Pediatr Hematol Oncol; 1984; 6(2):115-21. PubMed ID: 6589968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the intermittent prophylactic treatment of the central nervous system in adults with acute leukemia.
    Kawamura S; Mikami T; Iwamura H; Sawada Y; Yamaya T; Haneda Y; Sakata Y; Chiba Y; Yoshida Y
    Biomed Pharmacother; 1987; 41(9-10):462-7. PubMed ID: 3482982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
    Bleyer WA; Coccia PF; Sather HN; Level C; Lukens J; Niebrugge DJ; Siegel S; Littman PS; Leikin SL; Miller DR
    J Clin Oncol; 1983 May; 1(5):317-25. PubMed ID: 6366138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reappraisal of the results of stopping therapy in childhood leukemia.
    George SL; Aur RJ; Mauer AM; Simone JV
    N Engl J Med; 1979 Feb; 300(6):269-73. PubMed ID: 282457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.